The global pharmacogenomics technologies market size and share was valued at USD 8.17 billion in 2024 and is expected to grow at a CAGR of 8.3% during the forecast period. In North America the market is driven by rapid adoption of precision medicine, strong research funding, and established clinical-genomics infrastructure, giving it a leading position in this high-growth arena. Regional...